{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T01:26:20Z","timestamp":1771550780352,"version":"3.50.1"},"reference-count":20,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,8,22]],"date-time":"2013-08-22T00:00:00Z","timestamp":1377129600000},"content-version":"vor","delay-in-days":1298,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2010,2]]},"DOI":"10.1016\/j.jacc.2009.08.077","type":"journal-article","created":{"date-parts":[[2010,2,17]],"date-time":"2010-02-17T04:28:50Z","timestamp":1266380930000},"page":"617-625","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Enoxaparin Anticoagulation Monitoring in the Catheterization Laboratory Using a New Bedside Test"],"prefix":"10.1016","volume":"55","author":[{"given":"Johanne","family":"Silvain","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farzin","family":"Beygui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annick","family":"Ankri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Bellemain-Appaix","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Pena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivier","family":"Barthelemy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guillaume","family":"Cayla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanessa","family":"Gallois","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophie","family":"Galier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominique","family":"Costagliola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Philippe","family":"Collet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gilles","family":"Montalescot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2009.08.077_bib1","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1001\/jama.297.17.1892","article-title":"Decline in rates of death and heart failure in acute coronary syndromes, 1999\u20132006","volume":"297","author":"Fox","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2009.08.077_bib2","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1093\/eurheartj\/ehn416","article-title":"Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology","volume":"29","author":"Van de Werf","year":"2008","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2009.08.077_bib3","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1056\/NEJMoa052711","article-title":"Enoxaparin versus unfractionated heparin in elective percutaneous coronary intervention","volume":"355","author":"Montalescot","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2009.08.077_bib4","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1093\/eurheartj\/ehn008","article-title":"Impact of anticoagulation levels on outcomes in patients undergoing elective percutaneous coronary intervention: insights from the STEEPLE trial","volume":"29","author":"Montalescot","year":"2008","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2009.08.077_bib5","first-page":"449","article-title":"A novel point-of-care assay for the monitoring of low-molecular weight heparins in the cardiac catheterization laboratory","volume":"20","author":"Marmur","year":"2008","journal-title":"J Invasive Cardiol"},{"key":"10.1016\/j.jacc.2009.08.077_bib6","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s11239-006-4383-5","article-title":"The use of a HEMOCHRON JR. HEMONOX point of care test in monitoring the anticoagulant effects of enoxaparin during interventional coronary procedures","volume":"21","author":"El Rouby","year":"2006","journal-title":"J Thromb Thrombol"},{"key":"10.1016\/j.jacc.2009.08.077_bib7","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1161\/01.CIR.0000136830.65073.C7","article-title":"Anti-Xa activity relates to survival and efficacy in unselected acute coronary syndrome patients treated with enoxaparin","volume":"110","author":"Montalescot","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2009.08.077_bib8","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1016\/S0735-1097(97)00094-6","article-title":"Dose-ranging trial of enoxaparin for unstable angina: results of TIMI 11A","volume":"29","year":"1997","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2009.08.077_bib9","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000180580","article-title":"Prediction of creatinine clearance from serum creatinine","volume":"16","author":"Cockcroft","year":"1976","journal-title":"Nephron"},{"key":"10.1016\/j.jacc.2009.08.077_bib10","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.clpt.2005.02.012","article-title":"Dosing strategy in patients with renal failure receiving enoxaparin for the treatment of non-ST-segment elevation acute coronary syndrome","volume":"77","author":"Hulot","year":"2005","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jacc.2009.08.077_bib11","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/S0735-1097(03)00653-3","article-title":"The impact on coagulation of an intravenous loading dose in addition to a subcutaneous regimen of low-molecular-weight heparin in the initial treatment of acute coronary syndromes","volume":"42","author":"Bijsterveld","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2009.08.077_bib12","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1016\/S0735-1097(02)02531-7","article-title":"A unique, low dose of intravenous enoxaparin in elective percutaneous coronary intervention","volume":"40","author":"Choussat","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2009.08.077_bib13","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1161\/01.CIR.103.5.658","article-title":"Percutaneous coronary intervention after subcutaneous enoxaparin pretreatment in patients with unstable angina pectoris","volume":"103","author":"Collet","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2009.08.077_bib14","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1067\/mhj.2001.113217","article-title":"Dalteparin in combination with abciximab during percutaneous coronary intervention","volume":"141","author":"Kereiakes","year":"2001","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2009.08.077_bib15","first-page":"163","article-title":"Reliable anticoagulation with enoxaparin in patients undergoing percutaneous coronary intervention: the Pharmacokinetics of Enoxaparin in PCI (PEPCI) study","volume":"61","author":"Martin","year":"2004","journal-title":"Cathet Cardiovasc Interv"},{"key":"10.1016\/j.jacc.2009.08.077_bib16","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/j.1365-2125.2005.02452.x","article-title":"Anti-factor Xa kinetics after intravenous enoxaparin in patients undergoing percutaneous coronary intervention: a population model analysis","volume":"60","author":"Sanchez-Pena","year":"2005","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jacc.2009.08.077_bib17","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1053\/euhj.2001.2779","article-title":"Enoxaparin is superior to unfractionated heparin for preventing clinical events at 1-year follow-up of TIMI 11B and ESSENCE","volume":"23","author":"Antman","year":"2002","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2009.08.077_bib18","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1001\/archinte.167.22.2423","article-title":"Intravenous low-molecular-weight heparins compared with unfractionated heparin in percutaneous coronary intervention: quantitative review of randomized trials","volume":"167","author":"Dumaine","year":"2007","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jacc.2009.08.077_bib19","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0002-8703(03)00121-2","article-title":"Safety and efficacy of unfractionated heparin versus enoxaparin in patients who are obese and patients with severe renal impairment: analysis from the ESSENCE and TIMI 11B studies","volume":"146","author":"Spinler","year":"2003","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2009.08.077_bib20","first-page":"45","article-title":"Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trial","volume":"292","author":"Ferguson","year":"2004","journal-title":"JAMA"}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109709039199?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109709039199?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T12:35:51Z","timestamp":1760013351000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109709039199"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2]]},"references-count":20,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2010,2]]}},"alternative-id":["S0735109709039199"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2009.08.077","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2010,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enoxaparin Anticoagulation Monitoring in the Catheterization Laboratory Using a New Bedside Test","name":"articletitle","label":"Article Title"},{"value":"Journal of the American College of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2009.08.077","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}